Skip to main content
Yusheng Han, MD, Pathology, Philadelphia, PA

YushengHanMD

Pathology Philadelphia, PA

Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Han?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 7 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    800 Spruce St
    Philadelphia, PA 19107
    Phone+1 215-829-5933

Summary

  • Dr. Yusheng Han, MD is a board certified pathologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Minnesota, and California. He is affiliated with Kaiser Permanente Roseville Medical Center and Kaiser Permanente Sacramento Medical Center.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine Surgical Pathology
    Montefiore Medical Center/Albert Einstein College of Medicine Surgical PathologyFellowship, Selective Pathology, 2011 - 2012
  • Pennsylvania Hospital of the University of Pennsylvania Health System
    Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2006 - 2010
  • Southeast University Medical College
    Southeast University Medical CollegeClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2025
  • MN State Medical License
    MN State Medical License 2012 - 2014
  • NY State Medical License
    NY State Medical License Active through 2013
  • PA State Medical License
    PA State Medical License 2006 - 2010
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical

Publications & Presentations

PubMed

Press Mentions

  • Burning Rock Reports First Quarter 2021 Financial Results
    Burning Rock Reports First Quarter 2021 Financial ResultsMay 25th, 2021
  • IPO Launch: Burning Rock Biotech Pursues $196 Million U.S. IPO
    IPO Launch: Burning Rock Biotech Pursues $196 Million U.S. IPOJune 8th, 2020